In 2016, Joe Tippens, a 67-year-old businessman from Oklahoma, faced a terminal cancer diagnosis with very little hope. Diagnosed with small cell lung cancer, he endured chemotherapy and radiation, but after months of aggressive treatment, his doctors gave him only a few months to live.

However, a surprising tip from a veterinarian friend changed everything. Tippens heard about a scientist who used an anti-parasitic drug, fenbendazole, to cure her cancer and even saved herself. This sparked what would later become known as the “Joe Tippens Protocol,” a combination of fenbendazole, CBD, and Theracurmin (a turmeric extract).

Tippens decided to give it a try. He started taking fenbendazole (sold over the counter as Panacur) alongside his regular treatments. Just three months later, he was cancer-free.

Fenbendazole is an antiparasitic drug used for decades in animals, but it hasn’t been approved by the FDA for human use. Despite this, Tippens’ story has inspired many cancer patients to try the protocol, reporting anecdotal successes in their own treatments.

The Science Behind the Protocol

Oncologist Dr. William Makis has treated patients using the protocol and reports positive results, especially with aggressive cancers like small cell lung cancer. Research suggests that fenbendazole works in various ways to combat cancer, such as boosting tumor-suppressing proteins, disrupting cancer cell growth, and reducing sugar intake by cancer cells.

Recent studies indicate that fenbendazole can starve cancer cells by affecting their energy metabolism, which leads to their death without harming normal cells. There are even animal studies that support fenbendazole’s potential as an effective cancer treatment.

Patient Success Stories

Donna Leland, a radio host diagnosed with Stage 3 cervical and endometrial cancer, credits the Tippens Protocol for her recovery. After choosing not to undergo traditional chemotherapy, she began using fenbendazole and ivermectin, another anti-parasitic drug. One year later, she remains cancer-free, with no signs of recurrence.

Leland, like many others, found hope in this alternative treatment, which is being embraced by people worldwide. The protocol has spread, particularly in China, where over 70,000 people have followed it after reading about Tippens’ story.

Challenges and Risks

Despite its growing popularity, the use of fenbendazole and other repurposed drugs in cancer treatment is controversial. The FDA has not approved these drugs for human cancer treatment, and many doctors remain hesitant to prescribe them due to regulatory and safety concerns. However, some integrative physicians, like Dr. Makis, advocate for the exploration of alternative treatments when conventional methods fail.

The use of anti-parasitic drugs like fenbendazole and ivermectin has sparked debate, but Tippens remains committed to spreading awareness, refusing to profit from his findings. His success story continues to inspire many, even as research into the broader use of these drugs for cancer treatment advances.

Looking Forward

As more patients and researchers explore the potential of repurposed anti-parasitic drugs, Tippens hopes that his story will help bring about a revolution in cancer treatment, allowing for more options beyond traditional therapies.

With ongoing research and growing patient success stories, the future of cancer treatment may be broader than we ever imagined.